DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Camila is a drug marketed by Mayne Pharma and is included in one NDA.
The generic ingredient in CAMILA is norethindrone. There are twenty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
A generic version of CAMILA was approved as norethindrone by GLENMARK GENERICS on July 22nd, 2010.
Pharmacology for CAMILA
|Drug Class||Progestin |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mayne Pharma||CAMILA||norethindrone||TABLET;ORAL-28||076177-001||Oct 21, 2002||AB1||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|